Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt, I Duijkers… - Contraception, 2008 - Elsevier
BACKGROUND: Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …
[PDF][PDF] Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open …
J Endrikat, S Parke, D Trummer, W Schmidt, I Duijkers… - Contraception, 2008 - core.ac.uk
Background: Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt… - …, 2008 - europepmc.org
Background Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
[引用][C] Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open …
J ENDRIKAT, S PARKE, D TRUMMER… - Contraception …, 2008 - pascal-francis.inist.fr
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined
oral contraceptive : results of two prospective, randomized, open-label studies CNRS Inist …
oral contraceptive : results of two prospective, randomized, open-label studies CNRS Inist …
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt, I Duijkers… - Contraception, 2008 - infona.pl
Attempts to improve the tolerability of combined oral contraceptives (COCs) have included
the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this has proved …
the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this has proved …
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt… - …, 2008 - contraceptionjournal.org
Background Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17 -estradiol (E2). However …
have included the substitution of ethinylestradiol (EE) with 17 -estradiol (E2). However …
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt… - 2008 - publikationen.sulb.uni-saarland.de
Background: Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt, I Duijkers… - 2008 - pubmed.ncbi.nlm.nih.gov
Background Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …
J Endrikat, S Parke, D Trummer, W Schmidt… - 2008 - publikationen.sulb.uni-saarland.de
Background: Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However …
[PDF][PDF] Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open …
J Endrikat, S Parke, D Trummer, W Schmidt, I Duijkers… - Contraception, 2008 - core.ac.uk
Background: Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …